Testosterone Phenylpropionate — Dosing, Cycles, Half-Life & Side Effects

Testosterone Phenylpropionate is an injectable testosterone ester with a half-life of 4-5 days (phenylpropionate ester; ester-chain extrapolation from Minto 1997 nandrolone PK data). Short-to-medium-acting testosterone ester with phenylpropionate chain; rarely monoester-sold clinically, primarily a Sustanon 250 component (approx 60mg of the 250mg blend). Primary risks include strong HPTA suppression. This page is educational harm-reduction reference compiled from peer-reviewed literature — not medical advice, not an endorsement, not a recommendation to use. Consult a licensed clinician before any decision.

Quick Facts

ClassEsters
Half-life4-5 days (phenylpropionate ester; ester-chain extrapolation from Minto 1997 nandrolone PK data)
Detection window21 days
AromatizationYes
HepatotoxicityNone
Suppression10/10
17α-alkylatedNo
Administrationinjectable

Typical Dosing Ranges

Common dose range: 100-200mg every 3 days

Cycle length: 8-12 weeks

Time to steady state: ~22 days

Dose ranges are compiled from published pharmacokinetic studies and community-reported usage. Where a value is community-reported rather than clinically studied, this page and its structured data flag it. Lower end of any range is always the safer starting point.

Stacking Considerations

  • No structural stacking blockers. Standard harm-reduction rules apply: minimize total androgen load, minimize oral exposure, and monitor bloodwork.

PCT Requirements

  • This compound causes clinically meaningful HPTA suppression. Post-cycle therapy is recommended.
  • Depot clearance estimate: ~23 days post-last-dose before SERM start (5 × apparent depot half-life of 108h).
  • Never stack two SERMs. Extend a single SERM (tamoxifen OR enclomiphene/clomiphene) rather than combining.
  • Use the cycle planner to generate a full protocol based on your complete stack, not this compound alone.

Side Effect Profile

  • Requires frequent injections (every 3 days)
  • Monoester form rarely available outside Sustanon

Known Interactions

  • Testosterone Cypionate + Letrozole

    minor — pharmacokinetic

    Letrozole is potent AI. Over-suppression of estrogen is possible.

    Recommendation: Start with very low doses. Monitor E2 closely to avoid crash.

    Monitor: Estradiol, Joint pain, Mood

  • Testosterone Cypionate + Primobolan (Methenolone Enanthate)

    minor — synergistic

    Good synergy with low sides. Common stack.

    Recommendation: Generally well-tolerated combination.

    Monitor: Standard bloodwork

Related compounds

Monitoring (Bloodwork & Vitals)

  • Comprehensive metabolic panel (baseline, mid-cycle, post-cycle)
  • Lipid panel (total cholesterol, HDL, LDL, triglycerides)
  • CBC (hemoglobin, hematocrit — watch for erythrocytosis)
  • Sex-hormone panel (Total T, Free T, Estradiol sensitive, SHBG, LH, FSH)
  • Blood pressure (weekly self-check; flag systolic >140 or diastolic >90)

Baseline bloodwork is recommended before any cycle. Discontinue if liver enzymes exceed 3× upper limit of normal or if hematocrit exceeds 54%.

Frequently Asked Questions

What is the half-life of Testosterone Phenylpropionate?

Testosterone Phenylpropionate has a half-life of approximately 4-5 days (phenylpropionate ester; ester-chain extrapolation from Minto 1997 nandrolone PK data). Clearance estimate: 108h × 5 = 540h = 22.5 days. This figure is used to determine injection frequency (for esters) and post-cycle clearance timing.

What is the typical dose range for Testosterone Phenylpropionate?

Commonly reported ranges for Testosterone Phenylpropionate: 100-200mg every 3 days. Cycle length: 8-12 weeks. These are compiled from published studies and community-reported usage — individual response varies and lower end is always preferred.

Does Testosterone Phenylpropionate suppress natural testosterone?

Testosterone Phenylpropionate causes severe suppression of the HPTA axis (score 10/10). Post-cycle therapy (PCT) is recommended after use.

Does Testosterone Phenylpropionate aromatize to estrogen?

Aromatization profile: Yes. An aromatase inhibitor may be warranted if estrogen-related side effects appear — but AI use should be symptom-driven, not prophylactic, to avoid crashing E2.

What is Testosterone Phenylpropionate typically used for?

Testosterone Phenylpropionate is commonly used for: Sustanon component, Short cycle protocols. Intended-use context does not imply safety — every use case carries the same underlying pharmacological risks.

Citations

  1. Minto CF et al.. 1997. J Pharmacol Exp Ther — Phenylpropionate ester PK class extrapolation - approximate half-life 4-5 days; component of Sustanon 250 blend
  2. Belkien L et al.. 1985. Acta Endocrinol (Copenh) — 19-nortestosterone phenylpropionate ester analog - supports 100-200mg E3D dosing frequency for phenylpropionate esters
  3. de Oliveira Vilar Neto JF et al.. 2021. Andrologia — AAS-induced hypogonadism - testosterone phenylpropionate class effect supports suppressionScore 10/10
  4. Bhasin S et al.. 2001. Am J Physiol Endocrinol Metab — Estradiol rise with supraphysiologic testosterone - class effect supports aromatizationRate 6/10
  5. Hartgens F, Kuipers H. 2004. Sports Medicine — Injectable testosterone esters minimal hepatic impact; phenylpropionate follows class
  6. Liu E et al.. 2025. Subst Use Misuse — AAS CV risk - testosterone phenylpropionate monoester rarely clinically used; class effect applies

Disclaimer

StackItSmart is an independent harm-reduction reference. The content above is compiled from peer-reviewed literature and is not medical advice, not an endorsement, and not a recommendation to use Testosterone Phenylpropionate. Performance-enhancing compounds carry legal, endocrine, cardiovascular, and hepatic risks. Consult a licensed clinician before any decision. StackItSmart does not provide sourcing, procurement, or dosing prescriptions.

Skip to main content